Clinical Trial Update: To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating camrelizumab plus SHR1020 for advanced melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Camrelizumab (camrelizumab)
• SHR1020

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Melanoma | Phase 2 | Status: UNKNOWN